Novo Nordisk's GLP-1 agonist Ozempic has become the first drug in the class to be approved by the FDA to reduce the risk of ...

In the latest development, the European Commission has asked the EMA's human medicines committee, the CHMP, to take a look at ...

Metsera and Maze Therapeutics have become the second and third biotechs to complete an initial public offering (IPO) on the ...

Vertex Pharma has secured FDA approval for its non-opioid pain drug suzetrigine, becoming the first new class of pain ...

Robert F Kennedy Jr's first confirmation hearing was a fractious affair, marked by tough questions about his prior ...

REGENXBIO is a longtime player in the gene therapy space, but one that’s yet to bring its own therapy to market (in the early ...

San Francisco-based Rad AI, which develops generative AI (GenAI) tools to improve radiology workflows, has raised $60 million ...

The growing use of AI has opened new avenues for healthcare marketers, revolutionising how they approach new initiatives.

President Trump will continue to pursue the policy of Medicare pricing negotiation introduced by former President Biden's ...

The industry is grappling with significant market shifts amidst emerging technologies and changing demands. Companies are now ...

The scale of the decline in Veru's shares despite the positive result may reflect the amplified expectations of investors for ...

However, significant barriers stand in the way of realising this promise on a worldwide scale, from manufacturing costs and ...